12.50
Phathom Pharmaceuticals Inc Aktie (PHAT) Neueste Nachrichten
How sentiment analysis helps forecast Phathom Pharmaceuticals Inc.Market Activity Report & AI Driven Stock Reports - newser.com
Is Phathom Pharmaceuticals Inc. stock a buy on dipsWeekly Profit Summary & Risk Managed Investment Entry Signals - newser.com
Does Phathom Pharmaceuticals Inc. fit your quant trading modelWeekly Stock Summary & Daily Stock Trend Reports - newser.com
Will Phathom Pharmaceuticals Inc. stock reach all time highs in 2025Trade Risk Report & Safe Entry Trade Signal Reports - newser.com
Is Phathom Pharmaceuticals Inc. stock positioned for digital transformationJuly 2025 Breakouts & Smart Money Movement Tracker - newser.com
Using economic indicators to assess Phathom Pharmaceuticals Inc. potentialJuly 2025 PreEarnings & Low Risk High Reward Ideas - newser.com
Statistical indicators supporting Phathom Pharmaceuticals Inc.’s strength2025 Price Targets & Free Long-Term Investment Growth Plans - newser.com
Phathom Pharmaceuticals (NASDAQ:PHAT) Stock Price Up 6.8%Still a Buy? - MarketBeat
Will Phathom Pharmaceuticals Inc. continue its uptrendDay Trade & AI Powered Market Trend Analysis - newser.com
Phathom Pharmaceuticals (NASDAQ:PHAT) Earns "Sell (D-)" Rating from Weiss Ratings - MarketBeat
Is Phathom Pharmaceuticals Inc. meeting your algorithmic filter criteriaJuly 2025 Short Interest & Long-Term Growth Plans - newser.com
Cantor Fitzgerald reiterates Phathom stock as top pick with $29 price target - Investing.com Canada
Leading vs lagging indicators on Phathom Pharmaceuticals Inc. performanceMarket Performance Report & Long-Term Capital Growth Strategies - newser.com
Why hedge funds are buying Phathom Pharmaceuticals Inc. stockJuly 2025 Decliners & Fast Exit Strategy with Risk Control - newser.com
Phathom Pharmaceuticals Hits Day Low of $10.33 Amid Price Pressure - Markets Mojo
When Will Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT) Breakeven? - simplywall.st
Phathom Pharmaceuticals appoints Sanjeev Narula as chief financial officer By Investing.com - Investing.com Nigeria
Phathom Pharmaceuticals (NASDAQ:PHAT) Shares Down 7.8%Here's What Happened - MarketBeat
Phathom Pharmaceuticals Appoints Sanjeev Narula as Chief Financial and Business Officer - citybiz
Phathom Pharmaceuticals, Inc. Appoints Sanjeev Narula as Chief Financial and Business Officer - MarketScreener
When is the best time to exit Phathom Pharmaceuticals Inc.Global Markets & Expert Approved Trade Ideas - newser.com
Phathom Pharmaceuticals appoints Sanjeev Narula as chief financial officer - Investing.com
Phathom Pharmaceuticals Appoints New Chief Financial Officer - TipRanks
Phathom Pharmaceuticals appoints Sanjeev Narula as chief financial and business officer - Investing.com
Using Bollinger Bands to evaluate Phathom Pharmaceuticals Inc.2025 Technical Overview & Stock Portfolio Risk Management - newser.com
Analyzing recovery setups for Phathom Pharmaceuticals Inc. investorsSwing Trade & Long-Term Safe Investment Ideas - newser.com
Will Phathom Pharmaceuticals Inc. see short term momentumQuarterly Growth Report & Low Drawdown Trading Strategies - newser.com
Tools to monitor Phathom Pharmaceuticals Inc. recovery probabilityJuly 2025 Summary & Safe Capital Preservation Plans - newser.com
How to integrate Phathom Pharmaceuticals Inc. into portfolio analysis toolsJuly 2025 Closing Moves & Smart Swing Trading Alerts - newser.com
How Phathom Pharmaceuticals Inc. stock reacts to Fed rate cutsQuarterly Portfolio Review & Long-Term Safe Investment Plans - newser.com
What Fibonacci levels say about Phathom Pharmaceuticals Inc. reboundMarket Risk Report & Daily Stock Momentum Reports - newser.com
How to build a custom watchlist for Phathom Pharmaceuticals Inc.July 2025 Decliners & Expert Verified Stock Movement Alerts - newser.com
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):